Tegafur and uracil plus leucovorin in advanced colorectal cancer: a phase II trial

Clinical colorectal cancer

Volumn 1, Issue 1, 2001, Pages 43-46

  Aranda, Enrique ^a   Antón Torres, Antonio ^b   Sastre, Javier ^c   Navarro, Matilde ^d   Rivera, Fernando ^e   Carrato, Alfredo ^f   Breton J J ^g   Aparicio, Jorge ^h   Fernández Martos, Carlos ⁱ   Díaz Rubio, Eduardo ^c  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^d CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^e HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^f HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^g HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^h HOSPITAL UNIVERSITARIO LA FE   (Spain)

ⁱ INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FOLINIC ACID; TEGAFUR; URACIL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COLORECTAL TUMOR; DISEASE FREE SURVIVAL; DRUG ADMINISTRATION; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; ORAL DRUG ADMINISTRATION; PATHOLOGY; PHASE 2 CLINICAL TRIAL; SURVIVAL; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; TEGAFUR; TREATMENT OUTCOME; URACIL;

EID: 0035342205     PISSN: 15330028     EISSN: None     Source Type: Journal    
DOI: 10.3816/CCC.2001.n.004     Document Type: Article

References (22)

1. Advanced Colorectal Cancer Meta-Analysis Project Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate J Clin Oncol 10 1992 896 903
2. Advanced Colorectal Cancer Meta-Analysis Project Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer J Clin Oncol 12 1994 960 969
3. Meta-analysis Group In Cancer Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer J Clin Oncol 16 1998 301 308
4. H Watanabe S Yamamoto T Naito Clinical results of oral UFT therapy for malignant tumors under cooperative study Jpn J Cancer Chemother 7 1980 1588 1596
5. M Murakami K Ota Clinical results of UFT therapy for malignant tumors under cooperative study Jpn J Cancer Chemother 7 1980 1579 1586
6. K Ota T Taguchi K Kimura Report on nationwide pooled data and cohort investigation in UFT phase II study Cancer Chemother Pharmacol 22 1988 333 338
7. ST Malik D Talbot PI Clarke Phase II trial of UFT in advanced colorectal and gastric cancer Br J Cancer 62 1990 1023 1025
8. R Pazdur Y Lassere V Rhodes Phase II trial of uracil and tegafur plus oral leucovorin: an effective oral regimen in the treatment of metastatic colorectal carcinoma J Clin Oncol 12 1994 2296 2300
9. R Pazdur Phase II study of UFT plus leucovorin in colorectal cancer Oncology 54 1997 19 23
10. M Gonzalez-Baron J Feliu I de la Gandara Efficacy of oral tegafur modulation by uracil and leucovorin in advanced colorectal cancer. A phase II study Eur J Cancer 31 1995 2215 2219
11. LB Saltz CG Leichman CW Young A fixed-ratio combination of uracil and Ftorafur (UFT) with low dose leucovorin. An active oral regimen for advanced colorectal cancer Cancer 75 1995 782 785
12. J Zar Biostatistical analysis 1984 Prentice Hall Englewood 378 379
13. E Aranda E Diaz-Rubio A Cervantes Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with weekly high-dose 48-hour continuous-infusion fluorouracil for advanced colorectal cancer: a Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD) study Ann Oncol 9 1998 727 731
14. R Pazdur J-Y Douillard J Skillings Multicenter phase III study of 5-fluorouracil (5-FU) or UFT in combination with leucovorin (LV) in patients with metastatic colorectal cancer Proc Am Soc Clin Oncol 18 1999 263a (Abstract #1009).
15. J Carmichael T Popiela D Radstone Randomized comparative study of Orzel (oral uracil/tegafur (UFT) plus leucovorin (LV)) versus parenteral 5-fluorouracil (5-FU) plus LV in patients with metastatic colorectal cancer Proc Am Soc Clin Oncol 18 1999 264a (Abstract #1015).
16. J Feliu M Gonzalez Baron E Espinosa Uracil and tegafur modulated with leucovorin: an effective regimen with low toxicity for the treatment of colorectal carcinoma in the elderly. Oncopaz Cooperative Group Cancer 79 1997 1884 1889
17. E Diaz-Rubio E Aranda M Martin Weekly high-dose infusion of 5-fluorouracil in advanced colorectal cancer Eur J Cancer 26 1990 727 729
18. E Diaz-Rubio E Aranda C Camps A phase II study of weekly 48 hour infusion with high-dose fluorouracil in advanced colorectal cancer: an alternative to biochemical modulation J Infus Chemother 41 1994 58 61
19. E Aranda A Cervantes J Dorta A phase II trial of weekly high dose continuous infusion 5-fluorouracil plus oral leucovorin in patients with advanced colorectal cancer. The Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD) Cancer 76 1995 559 563
20. E Aranda A Cervantes A Carrato Outpatient weekly high-dose continuous-infusion 5-fluorouracil plus oral leucovorin in advanced colorectal cancer. A phase II trial. Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD) Ann Oncol 7 1996 581 585
21. A de Gramont JF Bosset C Milan Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study J Clin Oncol 15 1997 808 815
22. CH Kohne P Schoffski H Wilke Effective biomodulation by leucovorin of high-dose infusion fluorouracil given as a weekly 24- hour infusion: results of a randomized trial in patients with advanced colorectal cancer J Clin Oncol 16 1998 418 426